The feasibility of using a digital tool to enhance mobilisation following abdominal cancer surgery-a non-randomised controlled trial.
Patrik KarlssonMalin Nygren-BonnierLars HenningsohnElisabeth RydwikMaria HagströmerPublished in: Pilot and feasibility studies (2023)
Using the Pedatim tablet to enhance mobilisation following abdominal cancer surgery was deemed feasible, but a randomised controlled trial is needed to determine the tool's effectiveness. The study process was determined to be feasible with revisions of the eligibility criteria needed before a future trial. Involving healthcare professionals and providing available technical support are important for future implementation.
Keyphrases
- papillary thyroid
- minimally invasive
- coronary artery bypass
- study protocol
- squamous cell
- randomized controlled trial
- healthcare
- current status
- clinical trial
- surgical site infection
- squamous cell carcinoma
- lymph node metastasis
- childhood cancer
- coronary artery disease
- phase iii
- quality improvement
- percutaneous coronary intervention
- open label
- atrial fibrillation